Hemopexin: A review of biological aspects and the role in laboratory medicine

Clinica Chimica Acta

Volumn 312, Issue 1-2, 2001, Pages 13-23

  Delanghe, Joris R ^a   Langlois, Michel R ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

Author keywords

Haptoglobin; Heme; Hemolysis; Hemopexin; Iron

Indexed keywords

CARBON MONOXIDE; HAPTOGLOBIN; HEME; HEMOPEXIN; HEMOPEXIN RECEPTOR; IRON; NITRIC OXIDE; RECEPTOR; UNCLASSIFIED DRUG;

ACUTE INTERMITTENT PORPHYRIA; ANTIOXIDANT ACTIVITY; DISEASE SEVERITY; ENDOCYTOSIS; GENETIC HETEROGENEITY; HEMOLYTIC ANEMIA; HOMEOSTASIS; HUMAN; IMMUNODIFFUSION; INTRAVASCULAR HEMOLYSIS; LABORATORY; LIVER CELL; NEPHELOMETRY; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; TURBIDIMETRY;

ANTIOXIDANTS; CHEMISTRY, CLINICAL; GENETIC HETEROGENEITY; HEME; HEMOPEXIN; HOMEOSTASIS; HUMANS; IRON; RECEPTORS, PEPTIDE; REFERENCE VALUES;

EID: 0034806977     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00586-1     Document Type: Review

References (109)

1. Hemopexin
2. Assessment of Rh disease by ratios of bilirubin to albumin and hemopexin to albumin in amniotic fluid
3. Hemopexin
4. Complete amino acid sequence of human hemopexin, the heme-binding protein of serum
5. Role of redox-reactive metals in the regulation of the metallothionein and heme oxygenase genes by heme and hemopexin
6. Use of hemopexin domains and monoclonal antibodies to hemopexin to probe the molecular determinants of hemopexin-mediated heme transport
7. Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains
8. Relating matrix metalloproteinase structure to function: Why the "hemopexin" domain?
9. The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): Structural implications for its function
10. Structural properties of matrix metalloproteinases
11. Matrix metalloproteinases: Structures, evolution, and diversification
12. 2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components
13. Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV
14. Hemopexin is localized to human chromosome 11
15. The hemopexin gene maps to the same location as the beta-globin gene cluster on human chromosome 11
16. Structure of the human hemopexin gene and evidence for intron-mediated evolution
17. Sites of formation of the serum proteins transferrin and hemopexin
18. Hemopexin is synthesized in peripheral nerves but not in central nervous system and accumulates after axotomy
19. Expression of protective proteins hemopexin and haptoglobin by cells of the neural retina
20. The rat and human hemopexin genes contain an identical interleukin-6 response element that is not a target of CAAT enhancer-binding protein isoforms
21. The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness
22. Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein
23. Haemopexin-mediated transport of heme into isolated rat hepatocytes
24. Hemopexin joins transferrin as representative members of a distinct class of receptor-mediated endocytic transport systems
25. Role of heme-hemopexin in human T-lymphocyte proliferation
26. The hemopexin receptor on the cell surface of human polymorphonuclear leukocytes
27. Hemopexin-dependent down-regulation of expression of the human transferrin receptor
28. Isolation of the hemopexin receptor from human placenta
29. Studies on hemoglobin metabolism: I. The kinetic properties of the plasma hemoglobin pool in normal man
30. Studies on hemoglobin metabolism: II. Pathways of hemoglobin iron metabolism in normal man
31. Heme binding by hemopexin: Evidence for multiple modes of binding and functional implications
32. Serum proteins as mediators of hemin efflux from red cell membranes: Specificity of hemopexin
33. Kinetics of heme interaction with heme-binding proteins: The effect of heme aggregation state
34. Exchange of heme among hemoglobins and between hemoglobin and albumin
35. Haematoporphyrin and OO′-diacetylhaematoporphyrin binding by serum and cellular proteins. Implications for the clearance of these photochemotherapeutic agents by cells
36. Lipid peroxidation and antioxidants as biomarkers of tissue damage
37. The effects of heme-binding proteins on the peroxidative and catalatic activities of hemin
38. Renal ischemia/reperfusion up-regulates heme oxygenase-1 (HSP32) expression and increases cGMP in rat heart
39. Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage
40. Heme and the vasculature: An oxidative hazard that induces antioxidant defenses in the endothelium
41. Newly recognized causes of atherosclerosis: The role of microorganisms and of vascular iron overload
42. Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice
43. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation
44. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation
45. Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation
46. Hemin binding and oxidation of lipoproteins in serum: Mechanisms and effect of the interaction of LDL with human macrophages
47. Cellular protection mechanisms against extracellular heme. Heme-hemopexin, but not free heme, activates the N-terminal c-jun kinase
48. Regulating the fate of mRNA: The control of cellular iron metabolism
49. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress
50. Iron and gene expression: Molecular mechanisms regulating cellular iron homeostasis
51. Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells
52. Heme-hemopexin-mediated induction of metallothionein gene expression
53. Transcription of genes encoding iron and heme acquisition proteins of Haemophilus influenzae during acute otitis media
54. Binding of heme-hemopexin complexes by soluble HxuA protein allows utilization of this complexed heme by Haemophilus influenzae
55. Iron acquisition and hemolysin production by Campylobacter jejuni
56. Outer membrane peptides of Yersinia pestis mediating siderophore-independent assimilation of iron
57. Coordination of nitric oxide by heme-hemopexin
58. The interaction of heme-hemopexin with CO
59. Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF
60. Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin
61. Hyaluronan-binding properties of human serum hemopexin
62. Regulation of hemopexin synthesis in degenerating and regenerating rat sciatic nerve
63. Respective roles of inflammation and axonal breakdown in the regulation of peripheral nerve hemopexin: An analysis in rats and in C57BL/Wlds mice
64. Hemopexin in the human retina: Protection of the retina against heme-mediated toxicity
65. Heme-mediated reactive oxygen species toxicity to retinal pigment epithelial cells is reduced by hemopexin
66. Amino acid sequence of the N-terminal region of human hemopexin
67. Hemopexin
68. Genetic studies of low-abundance human plasma proteins: VI. Polymorphism of hemopexin
69. Hemopexin: A unique genetic polymorphism in populations of African ancestry
70. Electroimmunoassay
71. Radioimmunoassay employing polyethylene-glycol (PEG) for measuring dilute concentrations of rat hemopexin, albumin and haptoglobin
72. Haptoglobin/hemopexin
73. A turbidimetric method for measuring protein in culture media
74. Proteins
75. The concentration of 21 serum proteins in normal children and adults
76. Plasma hemopexin and haptoglobin in hemolytic diseases of the newborn
77. Serum concentration of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months
78. Urinary proteins and red blood cell membrane negative charges in diabetes mellitus
79. Immunonephelometry of specific proteins in human seminal plasma
80. Electro-immunodiffusion of cerebrospinal fluid proteins. Determination of α2-HS, ceruloplasmin, β1A/β1C, hemopexin and IgA
81. Biological and clinical significance of haptoglobin polymorphism in humans
82. A new method for fast haptoglobin phenotyping and hemoglobin-binding capacity calculation based on capillary zone electrophoresis
83. Hemolytic anemias. Diagnosis and management
84. Brief report: Plasma concentrations of hemopexin, haptoglobin and heme in patients with various haemolytic diseases
85. Concentration of serum hemopexin in healthy children and adults and in those with a variety of hematological disorders
86. Serum proteins in normal pregnancy and mild pre-eclampsia
87. Serum protein changes in the pre-eclampsia-eclampsia syndrome
88. Changes in 40 serum proteins of post-menopausal women
89. Absence of beta globulin band in the serum protein electropherogram of a patient with liver disease
90. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda
91. Immunonephelometric quantification of free haemoglobin
92. Congenital anhaptoglobinemia versus acquired hypohaptoglobinemia
93. Reference range of serum haptoglobin is haptoglobin phenotype-dependent in blacks
94. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs
95. Non specific resistance against malaria pre-erythrocytic stages: Involvement of acute phase proteins
96. Depletion of plasma hemopexin in man by hematin injections
97. Hemopexin metabolism in patients with altered serum levels
98. Heme in the treatment of heme deficiency states
99. Rat hemopexin. Molecular cloning, primary structural characterization, and analysis of gene expression
100. Hemopexin decreases spontaneous chemiluminiscence of cold preserved liver after reperfusion
101. Serum haemopexin levels in patients with malignant melanoma
102. Evaluation of biochemical markers in breast cancer
103. Serum copper concentrations and hepatic enzyme induction during long-term therapy with anticonvulsants
104. Changes in serum proteins, -iron and -copper in swimmers before and after altitude training
105. Elevations of hemopexin levels in neuromuscular disease
106. Carrier detection in Duchenne muscular dystrophy: A review of current issues and approaches
107. Duchenne muscular dystrophy carrier detection using logistic discrimination: Serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination
108. Serum myoglobin in Duchenne muscular dystrophy carrier detection: A comparison with creatine kinase and hemopexin using logistic regression
109. Depletion of serum hemopexin in fulminant rhabdomyolysis. Evidence for an interaction of hemopexin with myoglobin-derived heme